Thermodynamic modulation of light chain amyloid fibril formation

被引:116
作者
Kim, YS
Wall, JS
Meyer, J
Murphy, C
Randolph, TW
Manning, MC
Solomon, A
Carpenter, JF
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN 37920 USA
[3] Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA
关键词
D O I
10.1074/jbc.275.3.1570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To obtain further insight into the pathogenesis of amyloidosis and develop therapeutic strategies to inhibit fibril formation we investigated: 1) the relationship between intrinsic physical properties (thermodynamic stability and hydrogen-deuterium (H-D) exchange rates) and the propensity of human immunoglobulin light chains to form amyloid fibrils in vitro; and 2) the effects of extrinsically modulating these properties on fibril formation. An amyloid-associated protein readily formed amyloid fibrils in vitro and had a lower free energy of unfolding than a homologous nonpathological protein, which did not form fibrils in vitro. H-D exchange was much faster for the pathological protein, suggesting it had a greater fraction of partially folded molecules. The thermodynamic stabilizer sucrose completely inhibited fibril formation by the pathological protein and shifted the values for its physical parameters to those measured for the nonpathological protein in buffer alone. Conversely, urea sufficiently destabilized the nonpathological protein such that its measured physical properties were equivalent to those of the pathological protein in buffer, and it formed fibrils. Thus, fibril formation by light chains is predominantly controlled by thermodynamic stability; and a rational strategy to inhibit amyloidosis is to design high affinity ligands that specifically increase the stability of the native protein.
引用
收藏
页码:1570 / 1574
页数:5
相关论文
共 39 条
[1]   PROTEIN-FOLDING INTERMEDIATES - NATIVE-STATE HYDROGEN-EXCHANGE [J].
BAI, YW ;
SOSNICK, TR ;
MAYNE, L ;
ENGLANDER, SW .
SCIENCE, 1995, 269 (5221) :192-197
[2]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[3]   Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution [J].
Chang, BS ;
Beauvais, RM ;
Arakawa, T ;
Narhi, LO ;
Dong, AC ;
Aparisio, DI ;
Carpenter, JF .
BIOPHYSICAL JOURNAL, 1996, 71 (06) :3399-3406
[4]   Biology and therapy of immunoglobulin deposition diseases [J].
Dhodapkar, MV ;
Merlini, G ;
Solomon, A .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) :89-&
[5]   INFRARED SPECTROSCOPIC STUDIES OF LYOPHILIZATION-INDUCED AND TEMPERATURE-INDUCED PROTEIN AGGREGATION [J].
DONG, AC ;
PRESTRELSKI, SJ ;
ALLISON, SD ;
CARPENTER, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :415-424
[6]   PROTEIN FOLDING STUDIED USING HYDROGEN-EXCHANGE LABELING AND 2-DIMENSIONAL NMR [J].
ENGLANDER, SW ;
MAYNE, L .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1992, 21 :243-265
[7]   Protein aggregation: folding aggregates, inclusion bodies and amyloid [J].
Fink, AL .
FOLDING & DESIGN, 1998, 3 (01) :R9-R23
[8]  
Freire E, 1998, ADV PROTEIN CHEM, V51, P255
[9]   RENAL MEDULLARY ORGANIC OSMOLYTES [J].
GARCIAPEREZ, A ;
BURG, MB .
PHYSIOLOGICAL REVIEWS, 1991, 71 (04) :1081-1115
[10]   Amyloidosis: A review of recent diagnostic and therapeutic developments [J].
Gillmore, JD ;
Hawkins, PN ;
Pepys, MB .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :245-256